Catherine London is the President of Consilium Strategic Communications US Inc. She has more than 23 years of global pharmaceutical and biotechnology experience working with a broad range of start ups and Fortune 100 and 500 companies.
Prior to joining Consilium in April 2019, Catherine served as an Executive Vice President and Head of Corporate Communications and Investor Relations at Bioasis Technologies, Inc. Catherine previously held the role of Head of Corporate Communications at Purdue Pharma and in director-level roles in corporate and product communications at Alexion Pharmaceuticals, Inc. and Boehringer Ingelheim Pharmaceuticals, Inc. Her expertise includes executive, corporate, scientific and financial communications, investor relations, public affairs, government and policy communications and business communications. Catherine has also held senior leadership roles at global consulting firms such as Resolute, Ruder Finn and the Chandler Chicco Companies, an inVentiv Health Company, which includes Chamberlain, Chandler Chicco and BioSector2.
Catherine began her career as a reporter and editor working at print and broadcast outlets in minor and major U.S. markets before taking a turn as a science journal editor and eventually making the transition to public affairs at the American Diabetes Association. Catherine has a BA in Journalism from Auburn University.